By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


H. Lee Moffitt Cancer Center & Research Institute 

12902 Magnolia Drive

Tampa  Florida  33612-9497  U.S.A.
Phone: 888-663-3488 Fax: n/a


Moffitt Cancer Center is …

  • Dedicated to one mission: to contribute to the prevention and cure of cancer.
  • A not-for-profit cancer center created by the Florida Legislature and opened on the campus of the University of South Florida in Tampa in 1986.
  • Named after H. Lee Moffitt, former Speaker of the Florida House of Representatives.
  • One of only 39 cancer center designated by the National Cancer Institute as a Comprehensive Cancer Center.
  • Ranked 13th in the U.S. News & World Report magazine’s “Best Hospitals” list of top cancer centers for 2005
  • A critical resource for the state of Florida, which ranks 2nd in the U.S. in both cancer incidence and mortality.
  • The site of the Bill & Beverly Young National Functional Genomics Center, funded by the U.S. Department of Defense.
  • A major cancer research center with scientific programs in Molecular Oncology; Drug Discovery; Immunology; Experimental Therapeutics; Health Outcomes & Behavior; and Risk Assessment, Detection & Intervention.
  • A center for translational research whose researchers and physicians are committed to improving cancer care by moving discoveries quickly from laboratory bench to patient bedside and into the community.
  • The recipient of more than $50 million annually in sponsored research awards.
  • The largest provider of blood and marrow transplants in the Southeastern U.S.
  • A major economic engine that employed 2,655 people and generated $361 million in direct output in 2005.

Moffitt Cancer Center provides …
  • Compassionate care through more than 200,000 outpatient visits and 6,000 admissions per year on site.
  • Statewide service, impacting 20 percent of cancer cases in Florida through a network of 16 hospital and practice affiliations and more than 400 oncologists.
  • Access to clinical trials – with more than 200 ongoing clinical trials encompassing new and established procedures in chemotherapy, surgery, radiation, and immunotherapy.
  • Screening and prevention services to more than 20,000 people per year, including genetic screening and counseling; smoking cessation programs; clinics for patients at high risk for cancer; mammography and other tests; and a wide array of community education and outreach programs.
  • Comprehensive training, in partnership with the University of South Florida College of Medicine, in all aspects of cancer treatment, research and prevention for medical students, post-graduate fellows, residents, and community physicians.
  • Cancer Answers to anyone with a question related to cancer prevention, early detection, diagnosis, treatment and research via 1-888-MOFFITT, a toll-free information line staffed by registered nurses.

Last Updated: 12-27-2006

Key Statistics

Ownership: Private

Web Site: H. Lee Moffitt Cancer Center & Research Institute

Company News
Hearst Invests In H. Lee Moffitt Cancer Center & Research Institute Subsidiary M2Gen 9/20/2017 6:30:07 AM
Researchers At H. Lee Moffitt Cancer Center & Research Institute Using ActiGraph CentrePoint Data Hub In Quality-of-Life Study 4/27/2017 12:12:27 PM
Vycellix And H. Lee Moffitt Cancer Center & Research Institute Announce A Collaborative Research Study To Evaluate Novel Product Candidates For Improving Adoptive Cell Immunotherapies For Cancer 2/27/2017 7:34:25 AM
H. Lee Moffitt Cancer Center & Research Institute And Aptose Biosciences To Present Data On A Novel Class Of Dual-Targeting Bromodomain / Kinase Inhibitors At 57th Annual American Society of Hematology Meeting 12/3/2015 7:55:19 AM
HealthMyne And H. Lee Moffitt Cancer Center & Research Institute Sign Imaging Analytics Technology Agreement 10/6/2015 12:46:25 PM
Bristol-Myers Squibb (BMY) And H. Lee Moffitt Cancer Center & Research Institute Enter Into A Collaboration Agreement As Part Of U.S. Immuno-Oncology Rare Population Malignancy Program 9/25/2015 8:39:22 AM
Signal Genetics LLC (SGNL) And H. Lee Moffitt Cancer Center & Research Institute Enter Into Sponsored Research Agreement In Multiple Myeloma 9/8/2015 10:45:10 AM
H. Lee Moffitt Cancer Center & Research Institute Announces First Patient In Nation Treated With KTE-C19 In Kite Pharma (KITE)'s Clinical Trial For Non-Hodgkin's Lymphoma 6/2/2015 1:59:21 PM
Rosetta Genomics Ltd. (ROSG) Announces Selection Of First Pilot Project Grant Under Strategic Alliance With H. Lee Moffitt Cancer Center & Research Institute 5/26/2015 10:33:47 AM
Cancer Genetics, Inc. (CGIX) Enters Into Multi-Year Research Collaboration With H. Lee Moffitt Cancer Center & Research Institute For Genomics-Based Prediction Of Side Effects Associated With Chemotherapy 5/6/2015 7:38:44 AM